Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.81% |
| 2 | Technology | 15.51% |
| 3 | Consumer Discretionary | 11.84% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
MediaAlpha
MAX
$756M
| $1.33M | ﹤0.01% |
134,000
+89,300
| +200% | +$984K |
|
|
ME
2352
DELISTED
23andMe Holding Co
ME
| $1.33M | ﹤0.01% |
30,845
-29,520
| -49% | -$1.72M |
|
|
LITB
2353
LightInTheBox
LITB
$56.5M
| $1.33M | ﹤0.01% |
180,389
-15,506
| -8% | -$102K |
|
2354
Live Ventures
LIVE
$29.6M
| $1.33M | ﹤0.01% |
42,499
-4,000
| -9% | -$101K |
|
2355
Madrigal Pharmaceuticals
MDGL
$11.8B
| $1.33M | ﹤0.01% |
+4,582
| New | +$448K |
|
2356
Hurco Companies Inc
HURC
$142M
| $1.33M | ﹤0.01% |
50,806
-7,291
| -13% | -$181K |
|
2357
Principal Financial Group
PFG
$24.7B
| $1.33M | ﹤0.01% |
+15,822
| New | +$1.36M |
|
2358
Sensus Healthcare
SRTS
$49.1M
| $1.33M | ﹤0.01% |
178,734
-87,300
| -33% | -$787K |
|
2359
Scholar Rock
SRRK
$6.31B
| $1.32M | ﹤0.01% |
146,400
+69,000
| +89% | +$553K |
|
2360
ARKO Corp
ARKO
$818M
| $1.32M | ﹤0.01% |
152,900
+46,500
| +44% | +$431K |
|
2361
HUTCHMED
HCM
$2.06B
| $1.32M | ﹤0.01% |
89,552
-2,400
| -3% | -$26.2K |
|
2362
PAR Technology
PAR
$706M
| $1.32M | ﹤0.01% |
50,800
+18,033
| +55% | +$464K |
|
2363
Universal Insurance Holdings
UVE
$1.25B
| $1.32M | ﹤0.01% |
+125,000
| New | +$1.27M |
|
2364
Viemed Healthcare
VMD
$363M
| $1.32M | ﹤0.01% |
175,100
-89,300
| -34% | -$605K |
|
|
RTC
2365
DELISTED
Baijiayun Group
RTC
| $1.32M | ﹤0.01% |
28,179
-3,060
| -10% | -$119K |
|
2366
Immersion
IMMR
$246M
| $1.32M | ﹤0.01% |
187,300
-229,713
| -55% | -$1.48M |
|
2367
Peoples Financial Services
PFIS
$716M
| $1.32M | ﹤0.01% |
25,381
-2,774
| -10% | -$148K |
|
2368
Global Net Lease
GNL
$1.91B
| $1.31M | ﹤0.01% |
104,600
+27,000
| +35% | +$335K |
|
2369
Vanguard Consumer Discretionary ETF
VCR
$6.24B
| $1.31M | ﹤0.01% |
+6,000
| New | +$1.41M |
|
2370
Cumberland Pharmaceuticals
CPIX
$115M
| $1.31M | ﹤0.01% |
581,963
-14,900
| -2% | -$34.6K |
|
2371
Hooker Furnishings Corp
HOFT
$163M
| $1.3M | ﹤0.01% |
69,700
-10,765
| -13% | -$174K |
|
2372
Nurix Therapeutics
NRIX
$2.62B
| $1.3M | ﹤0.01% |
118,700
+45,400
| +62% | +$548K |
|
|
GHG
2373
GreenTree Hospitality
GHG
$115M
| $1.3M | ﹤0.01% |
350,804
-28,700
| -8% | -$87.9K |
|
2374
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.7B
| $1.3M | ﹤0.01% |
45,800
+22,700
| +98% | +$622K |
|
2375
Lennar Class B
LEN.B
$20.1B
| $1.29M | ﹤0.01% |
18,200
-28,248
| -61% | -$1.83M |
|
Similar funds
Renaissance Technologies's Q4 2022 Portfolio in Review
As of Q4 2022, Renaissance Technologies held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Renaissance Technologies added most to Apple in Q4 2022, an estimated $839M increase.
- Renaissance Technologies's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Renaissance Technologies fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Renaissance Technologies's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Renaissance Technologies opened 626 new positions and closed 524 in Q4 2022.
- Renaissance Technologies's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.